Study to Evaluate the Safety and Clinical Activity of UCART123 in Patients With BPDCN

You may be eligible if

• Patients with a diagnosis BPDCN according to World Health Organization (WHO) classification confirmed by hematopathology;
• Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1;